Ghl Pharma & Diagnostic Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 06-11-2024
- Paid Up Capital ₹ 10.01 Cr
as on 06-11-2024
- Company Age 2 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
About Ghl Pharma & Diagnostic
The Corporate was formerly known as Global Health Pharmaceutical Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 10.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Ghl Pharma & Diagnostic Private Limited India are Anup Jha as CFO and Sanchit Ralhan as Company Secretary. Rajdeep Panwar, Yogesh Gupta, Naresh Trehan, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110DL2022PTC400942
- Company No.
400942
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2022
- Date of AGM
19 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ghl Pharma & Diagnostic?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anup Jha | CFO | 09-Aug-2023 | Current |
| Sanchit Ralhan | Company Secretary | 01-Sep-2022 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajdeep Panwar  | Director | 19-Sep-2023 | Current |
| Yogesh Gupta | Additional Director | 18-Apr-2024 | Current |
| Naresh Trehan | Director | 29-Jun-2022 | Current |
| Pankaj Sahni | Director | 29-Jun-2022 | Current |
Financial Performance and Corporate Structure Insights of Ghl Pharma & Diagnostic.
Ghl Pharma & Diagnostic Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ghl Pharma & Diagnostic?
In 2023, Ghl Pharma & Diagnostic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Medanta Holdings Private LimitedActive 11 years 8 months
Naresh Trehan and Pankaj Sahni are mutual person
- Global Health Patliputra Private LimitedActive 9 years 4 months
Naresh Trehan and Pankaj Sahni are mutual person
- Global Health Institute Of Medical Sciences FoundationInactive For E-Filing 8 months 21 days
Naresh Trehan and Pankaj Sahni are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ghl Pharma & Diagnostic?
Ghl Pharma & Diagnostic has a workforce of 170 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ghl Pharma & Diagnostic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ghl Pharma & Diagnostic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
